Ivy Foundation Translational Adult Glioma Grant Award 2022

Program Description

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma.  This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.

Eligibility

• A PhD, MD or equivalent is required.
• Only one submission per applicant is permitted every calendar year.
• Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
• The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.
• Clinical trials eligible

Award Terms

• $600,000 total, payments received at initiation and completion of project
• Project duration is 24 months
• Indirect costs not to exceed 10% (included in award total-$60,000 maximum)
• One Principal Investigator allowed; Co-Investigators permitted

Key Dates

• March 1, 2022: Application Due Date (Please do not send before January 1, 2022)
• May 1, 2022: Selection of Awardees
• June 15, 2022: Signed Agreements Due
• July 1, 2022: Award Start Date

Application Information Required

• Contact Information (name, phone, address, email and assistant contact information)
  • Use one page Title Page template
• Project Title and Description
  •  4 Page Maximum including graphs, photos, etc.
  • Minimum 10-point font size with one inch margins
• Principal Investigator’s Biography
  •  6 page maximum
  • NIH Biosketch
• Co-Investigator’s Biography
  • 1 page maximum
• List of All Current Funding
  • 50-word project description, affiliated parties, and direct costs per year
• Endorsements from institutional officials not necessary